Zinc involvement in opioid addiction and analgesia – should zinc supplementation be recommended for opioid-treated persons?

INTRODUCTION: Zinc chelators were shown to facilitate some opioid-withdrawal signs in animals. Zinc deficiency, which affects more than 15 % the world’s population, is also common among opioid consumers and opioid-treated animals exhibit misbalances of zinc distribution. AIM: The present study focus...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Subst Abuse Treat Prev Policy
Asıl Yazarlar: Ciubotariu, Diana, Ghiciuc, Cristina Mihaela, Lupușoru, Cătălina Elena
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2015
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4523930/
https://ncbi.nlm.nih.gov/pubmed/26238243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13011-015-0025-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller